GP Nolva (Nolvadex) is a non-steroidal antagonist of estrogens. Specifically binds to estrogen receptors in peripheral and tumor tissues. Thus, eliminates the effect of estrogens produced in the body and stimulating the growth of cancer cells.
Slows the progression of the tumor process. After taking a single dose a few weeks will retain the ability to block estrogens. Causes ovulation in women, in men with oligospermia increases the level of LH and FSH.
The active substance group:
During treatment Nolvadex should regularly monitor the level of platelets and blood calcium, during prolonged use of the drug monitoring Nolvadex shown ophthalmologist. During treatment is not recommended to perform work requiring high concentration. It should not be combined with drugs, containing hormones, especially estrogen .If simultaneous appointment with drugs that affect blood clotting, a correction of the dose of the drug Nolvadex. When combined appointment of the risk of thrombosis increases with other cancer drugs.
Bone pain and lesions nausea, vomiting, fever rash, itching in the genital area hair loss, swelling, vaginal bleeding depression, dizziness, headache, inflammation of the veins, visual disturbances.